Simplex Trading’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-32
Closed -$3.11K 9592
2025
Q4
$3.11K Sell
32
-223
-87% -$19.1K ﹤0.01% 7670
2025
Q3
$18K Buy
+255
New +$17K ﹤0.01% 7409
2025
Q2
Sell
-907
Closed -$47K 9170
2025
Q1
$47K Buy
907
+300
+49% +$16.9K ﹤0.01% 5832
2024
Q4
$33K Buy
+607
New +$31.9K ﹤0.01% 6259
2024
Q1
Sell
-37
Closed -$1.64K 9318
2023
Q4
$1K Sell
37
-257
-87% -$10.8K ﹤0.01% 8507
2023
Q3
$13K Buy
+294
New +$13.7K ﹤0.01% 6983

Other funds holding IRMD

Simplex Trading's IRMD Position: Q1 2026 in Review

Simplex Trading sold out of iRadimed (IRMD) in Q1 2026, closing a stake of 32 shares — an estimated $3.11K sold.

Simplex Trading first reported a position in IRMD in Q3 2023 and held it in 6 quarters. The position peaked at $47K in Q1 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Simplex Trading reported no remaining iRadimed position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 32 iRadimed shares in Q1 2026, an estimated $3.11K.
  • Simplex Trading first reported a position in iRadimed in Q3 2023 and held it in 6 quarters.
  • Simplex Trading's iRadimed position peaked at $47K in Q1 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.